Pigmented progressive purpuric dermatosis - Pigmented Alualu I Luma Purpuric Dermatosis
https://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
☆ I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi. 
Schamberg disease ― o se tama e 26 tausaga le matua e iai se vaega o le asymptomatic pigmentation ma le telangiectasia i luga o le vae.
relevance score : -100.0%
References
Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260 NIH
Pigmented purpuric dermatoses (PPD) o se vaega o tulaga o le pa'u ua faailogaina i vaega laiti o le tafetoto i lalo o le pa'u ona o le mumu o capillary. E masani ona amata le PPD i lanu mumu i le lanu viole e liu enaena-auro mulimuli ane pe a toe fa'afo'i le hemosiderin.
Pigmented purpuric dermatoses (PPD) include several skin diseases characterized by multiple petechial hemorrhage as consequence of capillaritis. PPD generally present with red to purple macules that progressively evolve to golden-brown color as the hemosiderin is reabsorbed.
Schamberg Disease 32809367 NIH
Schamberg disease o le ituaiga sili ona taatele o pigmented purpuric dermatoses (PPDs) , o tulaga masani o le paʻu o loʻo faʻaalia e laiti lanu mumu poʻo le lanu viole, ma faʻateleina le lanu o le paʻu (pateti enaena, mumu, poʻo samasama) . O PPD e fa'avasegaina i ituaiga e lima: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura, eczematoid-like purpura of Doucas and Kapetanakis. Schamberg disease (SD) e lauiloa foi progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressiva, Schamberg's purpura. E masani ona afaina ai tane ma e masani lava ona aliali mai i vae pito i lalo, ae mafai foi ona tupu i luga o ogavae, papa, ogalaau, poʻo lima.
Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis. Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura. It is commonly seen in males and mainly affects the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.
Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156 NIH
O faʻamatalaga i luga o le 113 maʻi ma le PPD na suʻesuʻeina, e aofia ai le 38 oe na faia le biopsy paʻu mo lenei suʻesuʻega. Ole ma'i sili ona taatele ole ma'i Schamberg (60. 5%) . O isi tulaga fa'atasi ma le PPD o le toto maualuga (15. 8%) , ma'i suka (10. 5%) , ma isi. O tala fa'asolopito o vaila'au na fa'aalia ai statins (13. 2%) , beta blockers (10. 5%) , ma isi. O a'afiaga e ono feso'ota'i ma le PPD e aofia ai fa'ama'i pipisi o le manava pito i luga (5. 3%) , fa'aumi le tu e o'o atu i le maualuga o le mamafa (2. 6%) , ma fa'amalositino malosi (2. 6%) . Togafitiga sa faia i le 36 gasegase (94. 7%) - oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
Information on 113 patients with PPD was analyzed, and 38 subjects with skin biopsy were included for this study. Schamberg's disease was the most frequent clinical type (60.5%). Concomitant diseases included hypertension (15.8%), diabetes (10.5%), and others. Associated medication histories included statins (13.2%), beta blockers (10.5%), and others. Possibly associated etiologic factors were recent upper respiratory infection (5.3%), high orthostatic pressure due to prolonged standing (2.6%), and strenuous exercise (2.6%). A total of 36 patients (94.7%) were treated with one or more treatment methods, including oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
○ Togafitiga ― OTC Drugs
OTC steroid suauu
#Hydrocortisone ointment
#Hydrocortisone cream